SJH-CHS_NSABP B-51 (14-109)

NSABP B-51: A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chest Wall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients with Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy

Phase III
NCT01872975
All Other|Cancer
Breast
Ibrahim Shalaby, M.D.
NSABP (National Surgical Adjuvant Breast and Bowel Project)
Christy Ratheal
  • Covenant Health